Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype-adjusted Omeprazole Dosing in GERD
NCT00537732Phase 4Terminated
- Start
- Apr 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omeprazole in gastroesophageal reflux disease (GERD). Started Apr 2007; status: terminated.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00537732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537732.